{"orpha":213528,"name":"Rare adenocarcinoma of the breast","type":"Disease","group":"Disorder","status":"active","flags":[],"synonyms":[],"definition":"A rare malignant breast tumor disease encompassing special rare types of adenocarcinoma of the breast, i.e. tubular adenocarcinoma, mucinous carcinoma, medullary carcinoma NOS, papillary adenocarcinoma NOS, cribriform carcinoma, apocrine adenocarcinoma, secretory carcinoma, glycogen-rich clear cell carcinoma, lipid-rich carcinoma, and oncocytic carcinoma.","note":null,"url":"https://raremap.alftech.space/d/ORPHA-213528/","orphanet_url":"https://www.orpha.net/en/disease/detail/213528","names":{"fr":{"name":"Adénocarcinome rare du sein","definition":"Tumeur maligne rare du sein regroupant certaines formes rares particulières d'adénocarcinome du sein, à savoir l'adénocarcinome tubuleux, le carcinome mucineux, le carcinome médullaire (sans autre spécification), l'adénocarcinome papillaire (sans autre spécification), le carcinome cribriforme, l'adénocarcinome apocrine, le carcinome sécrétant, le carcinome à cellules claires (riches en glycogène), le carcinome riche en lipides et le carcinome oncocytaire."},"de":{"name":"Seltenes Adenokarzinom der Brust","definition":"Ein seltener maligner Mammatumor, der bestimmte Sonderformen des Adenokarzinoms der Brust umfasst, darunter das tubuläre Adenokarzinom, das muzinöse Karzinom und das medulläre Karzinom (nicht anderweitig spezifiziert), papilläres Adenokarzinom (nicht anderweitig spezifiziert), kribriformes Karzinom, apokrines Adenokarzinom, sekretorisches Karzinom, klarzelliges (glykogenreiches) Karzinom, lipidreiches Karzinom und onkozytäres Karzinom."},"es":{"name":"Adenocarcinoma raro de mama","definition":"Es una enfermedad tumoral maligna de la mama poco frecuente que engloba a otros tipos de adenocarcinoma de la mama, como adenocarcinoma tubular, carcinoma mucinoso, carcinoma medular NOS, adenocarcinoma papilar NOS, carcinoma cribiforme, adenocarcinoma apocrino, carcinoma secretor, carcinoma de células claras rico en glucógeno, carcinoma rico en lípidos y carcinoma oncocítico."},"it":{"name":"Adenocarcinoma raro della mammella","definition":"Si tratta di una neoplasia maligna rara della mammella, che comprende alcuni tipi rari di adenocarcinoma della mammella, ovvero l'adenocarcinoma tubulare, il carcinoma mucinoso, il carcinoma midollare NST, l'adenocarcinoma papillare NST, il carcinoma cribriforme, l'adenocarcinoma apocrino, il carcinoma secretorio, il carcinoma a cellule chiare ricco di glicogeno, il carcinoma ricco di lipidi e il carcinoma oncocitico."},"nl":{"name":"Zeldzaam adenocarcinoom van borst","definition":"Een zeldzame maligne tumor van borst die speciale zeldzame types van adenocarcinoom van borst omvat, i.e. tubulair adenocarcinoom, mucineus carcinoom, medullair carcinoom NOS, papillair adenocarcinoom NOS, cribriform carcinoom, apocrien adenocarcinoom, secretoir carcinoom, glycogeen-rijk heldercellig carcinoom, lipide-rijk carcinoom, en oncocytair carcinoom."},"pt":{"name":"Adenocarcinoma da mama raro","definition":"Doença tumoral maligna da mama, rara, que abrange formas raras e especiais de adenocarcinoma da mama, ou seja, adenocarcinoma tubular, carcinoma mucinoso, carcinoma medular NOS, adenocarcinoma papilar NOS, carcinoma cribriforme, adenocarcinoma apócrino, carcinoma secretor, carcinoma de células claras rico em glicogénio, carcinoma rico em lipídios e carcinoma oncocítico."},"pl":{"name":"Rzadki gruczolakorak piersi"},"cs":{"name":"Vzácný adenokarcinom prsu"},"uk":{"name":"Рідкісна аденокарцинома молочної залози","definition":"A rare malignant breast tumor disease encompassing special rare types of adenocarcinoma of the breast, i.e. tubular adenocarcinoma, mucinous carcinoma, medullary carcinoma NOS, papillary adenocarcinoma NOS, cribriform carcinoma, apocrine adenocarcinoma, secretory carcinoma, glycogen-rich clear cell carcinoma, lipid-rich carcinoma, and oncocytic carcinoma."},"zh":{"name":"罕见乳腺腺癌"},"tr":{"name":"Nadir meme adenokarsinomu"}},"xrefs":[{"source":"ICD-10","code":"C50.0","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.1","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.2","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.3","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.4","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.5","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.6","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-10","code":"C50.8","qualifier":"BTNT","icd_relation":"attributed","validated":true},{"source":"ICD-11","code":"2E65.Y","qualifier":"NTBT","icd_relation":"attributed","validated":true},{"source":"MONDO","code":"0016250","qualifier":"E","icd_relation":null,"validated":true},{"source":"UMLS","code":"C5680864","qualifier":"E","icd_relation":null,"validated":true}],"associations":[],"incoming_associations":[],"preferential_parent":{"orpha":250908,"name":"Rare neoplastic disease"},"parents":[{"orpha":180257,"name":"Rare malignant breast tumor","classifications":[202,205]}],"children":[],"genes":[],"genes_via_subtypes":[],"inheritance":[],"onset":["Adult"],"prevalence":[{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.55,"area":"Europe","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 1 000 000","value":0.898,"area":"Lithuania","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.325,"area":"Austria","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.221,"area":"Belgium","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.397,"area":"Bulgaria","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.175,"area":"Croatia","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.717,"area":"Czech Republic","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.371,"area":"Estonia","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.615,"area":"Finland","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.812,"area":"Germany","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.428,"area":"Iceland","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.305,"area":"Ireland","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":4.103,"area":"Italy","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":1.191,"area":"Latvia","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.199,"area":"Malta","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.017,"area":"Norway","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":1.812,"area":"Poland","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":1.697,"area":"Portugal","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.171,"area":"Slovakia","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.315,"area":"Slovenia","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":2.142,"area":"Spain","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.187,"area":"Switzerland","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.264,"area":"Netherlands","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"},{"type":"Annual incidence","qualification":"Value and class","class":"1-9 / 100 000","value":3.638,"area":"United Kingdom","status":"Validated","source":"RARECARE surveillance of rare cancers in Europe[OTHER]"}],"phenotypes":null}